Triple-negative breast cancer (TNBC) is molecularly defined by the absence of expression of three prognostically significant receptors: the progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) [3]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.